Multicenter randomized phase II study of short course FOLFOX + nivolumab (Nivo) followed by maintenance Nivo +/- radiation (RT) in the first line treatment of metastatic or unresectable gastroesophageal adenocarcinoma (mGEA).
Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Manish A. Shah, Sarbajit Mukherjee, Kelsey Klute, Debra D'Angelo, Sahrish Khan, Nicholas J. Sanfilippo, Paul J. Christos, Jessica M. Frakes, Jessica Delaney, Sarah Chatley, Kian-Huat Lim, Haeseong Park, Rutika Metha
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Bristol-Myers Squibb
Award: G6943420300
OpenAlex ID: W4399736367